Indian pharmaceutical company Biocon Ltd has announced that it will begin selling a generic version of the breast cancer drug Herceptin to patients in India in February, a move that promises to make breast cancer treatment more accessible in a region …
http://ift.tt/eA8V8J
0 comments:
Post a Comment